|
2024
|
Invention
|
Crystal form or salt of bicyclic heteroaryl amide compound, preparation method therefor and use t... |
|
|
Invention
|
Rnai agent for inhibiting expression of lpa and use of rnai agent. Provided is an RNAi agent for ... |
|
|
Invention
|
Cyclic amine derivative, and composition and use thereof. The present invention relates to a cycl... |
|
|
Invention
|
Cyclohexane derivative, pharmaceutical composition thereof and use thereof. 131A1A receptor, for ... |
|
2023
|
Invention
|
Ligand-oligonucleotide conjugate and linker for conjugate. A ligand-oligonucleotide conjugate and... |
|
2022
|
Invention
|
Fused bicyclic heteroaryl amide compound as protein aggregation inhibitor.
Provided are a fused ... |
|
|
Invention
|
Fused bicyclic heteroaryl amide compound as protein aggregation inhibitor. Provided are a fused b... |
|
2020
|
Invention
|
Blood coagulation factor xia inhibitor. A blood coagulation factor XIa inhibitor of formula I, a ... |
|
2019
|
Invention
|
Salt of cyclohexane derivative. The present invention provides a maleate, phosphate, sulfate, hyd... |
|
|
Invention
|
Salt of cyclohexane derivative. The present invention provides a maleate, phosphate, sulfate, and... |
|
|
Invention
|
Method for preparing cyclohexane derivative. The present invention provides a method for preparin... |
|
|
Invention
|
Method for preparing cyclohexane derivative. Provided is a method for preparing a cyclohexane der... |
|
2018
|
Invention
|
Benzodiazepine compound solid forms, and preparation methods therefor and applications thereof. D... |
|
|
Invention
|
Stable oral pharmaceutical composition and preparation method therefor. Disclosed are a stable or... |
|
2017
|
Invention
|
Genetically engineered bacterium of coexpressing cyclohexanone monooxygenase and isopropanol dehy... |
|
|
Invention
|
Crystal form of tasimelteon. Crystal forms I and II of tasimelteon. Crystal form I: an X-ray powd... |
|
2016
|
Invention
|
Substituted ureas and methods of treating mental illness using the same. 2 receptors, and can be ... |
|
|
Invention
|
Cyclohexane derivative or stereoisomer or salt thereof, and preparation and use thereof. Provided... |
|
2014
|
Invention
|
Treatment of sleep disorders. The use of 7-chloro-3-(5-dimethylaminomethyl-[1,2,4]oxadiazol-3-yl)... |
|
2003
|
P/S
|
Raw materials (for medicine). Pharmaceutical preparations; chemico-pharmaceutical
preparations; ... |
